Your Shopping Cart Is Empty
| Report Code: A13139 | Aug 2021 | Pages: 292 | ||
| Tables: 140 | Charts: 67 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Isoflavones Market
Request Now !The global isoflavones market size was valued at $975.0 million in 2020, and is projected to reach $1,707.5 million by 2030, registering a CAGR of 5.8%.
Isoflavones are polyphenolic compounds that have both estrogen-agonist and estrogen-antagonist properties. The most active isoflavones found in soy beans are genistein, daidzein, and glycitein, which are phytoestrogens with strong estrogenic activity. Numerous clinical studies have found genistein and daidzein to be beneficial in the prevention of breast and prostate cancer, cardiovascular disease, and osteoporosis as well as in the relief of postmenopausal symptoms.
A major factor influencing the market growth is rising consumer preference for natural products. Consumers' growing concerns about preventive healthcare and the efficacy of isoflavones on health are driving the market growth. Isoflavones demand has increased due to an increase in functional food consumption, which, in addition to providing basic nutrition, has the potential to improve health.
Obesity, digestive problems, gastrointestinal infections, vaginal infections, and other ailments affect the vast majority of people today. Taking this into consideration, market players are developing isoflavones products to help with the treatment of such diseases. The impact of growing health concerns on the isoflavones market is moderate at the moment, but it is expected to increase in the near future.
When compared to a placebo, treatment with soy isoflavones improves nonverbal memory, construction abilities, verbal fluency, and dexterity in geriatrics. Geriatrics is the medical care given to older adults, an age group that is difficult to define precisely. Many trials have been carried out to investigate the potential cognitive benefits of soy isoflavones in Alzheimer's disease patients, and every trial resulted in a successful outcome. As a result, the rapidly growing geriatric population will drive the market growth.
The food & beverages industry growth due to increased consumer spending and favorable government support is expected to be a major driving factor in the isoflavones market growth. The isoflavones market demand is expected to be driven by rising demand for fortified foods among health-conscious consumers. However, stringent government regulations in the industry are expected to impede the market growth.
The growing awareness of the health benefits of isoflavones, combined with aging population, is expected to provide isoflavones market opportunity. The isoflavones market is expected to grow due to an increase in the number of working women and rising consumers’ purchasing ability of healthy food products.
COVID-19 had a moderate impact on the isoflavones market. Isoflavones are widely used in a variety of products, including dietary supplements, pharmaceuticals, and nutraceuticals. Products containing isoflavones are used to improve muscle mass and immunity. This factor led to a high demand for isoflavones products in the market.
Growing health concerns and increased consumer awareness have increased consumer demand for isoflavones, resulting in an increase in fortified food demand. In addition to available medical health supplements, consumers prefer isoflavones dietary supplements as they are plant-based.
A significant increase in demand for nutraceutical supplements across all age groups, combined with an increase in global disposable income, is a major driving force for the market growth. Geriatrics is becoming a global trend in both developed and developing countries. Consumers across the world are becoming more concerned with changes in their quality of life and are paying close attention to the foods they consume. Attributed to an increase in the number of working mothers globally, increased consumption of infant formula containing flavonoids is expected to drive the market growth. As a result of the increased demand for isoflavone products from emerging markets, the isoflavones market will have lucrative opportunities for growth.
The isoflavones market is segmented on the basis of source, application, form, and region. On the basis of source, it is categorized into soy, red clover, and others. As per application, it is divided into pharmaceuticals, nutraceuticals, cosmetics, and food & beverages. According to form, it is fragmented into powder and liquid. Region-wise, the isoflavones market analysis is done across North America, Europe, Asia-Pacific, and LAMEA. By considering all these segments, isoflavones market forecast is done.
By source, the soy segment garnered the highest isoflavones market share in 2020 due to rising consumer awareness of the benefits of consuming soy isoflavones in regular diet such as the prevention and treatment of heart disease, asthma, diabetes, and multiple cancers. On the basis of application, the pharmaceuticals segment is anticipated to dominate with the highest market share during the forecast period. This is attributed to the growing application of isoflavones due to their therapeutic and functional properties. By form, the powder segment led the market in 2020. This is attributed to isoflavones market trends such as ease of handling and use of isoflavones in a wide range of pharmaceutical and nutraceutical applications.
The prominent isoflavones industry players include Cargill, Archer-Daniels-Midland (ADM) Company, Badische Anilin und Soda Fabrik (BASF), DSM, International Flavors and Fragrances, Shanghai Freemen, Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Herbo Nutra, and NutraScience Labs.
The most important growth strategy used by the market players is product launch, which is followed by collaboration, agreement, expansion, and acquisition. To diversify their product offerings, several businesses have developed innovative products. Product launches are used by a variety of businesses to broaden their market reach and serve international customers.
Key Benefits For Stakeholders
Key Market Segments
By Source
By Application
By Form
By Region
Isoflavones Market Report Highlights
| Aspects | Details |
|---|---|
| By SOURCE |
|
| By APPLICATION |
|
| By FORM |
|
| By Region |
|
| Key Market Players | Herbo Nutra, Cargill, Inc., International Flavors and Fragrances, NutraScience Labs, BASF SE, Archer-Daniels-Midland Company (ADM), DSM, Shanghai Freemen, Nexira Inc, Biomax Life Sciences Limited |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Snapshot
2.2.Key findings
2.2.1.Top investment pocket
2.3.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key forces shaping the global isoflavones market
3.2.1.Bargaining power of suppliers
3.2.2.Bargaining power of buyers
3.2.3.Thereat of new entrants
3.2.4.Threat of substitutes
3.2.5.Intensity of competitive rivalry
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rising prevalence of cancer and cardiovascular diseases
3.3.1.2.Prevalence of menopausal issues
3.3.1.3.Rising demand for fortified food owing to increasing health consciousness amongst consumers
3.3.1.4.Rapidly increasing geriatric population
3.3.2.Restraints
3.3.2.1.Stringent regulatory requirements
3.3.2.2.Less efficiency compared to alternatives
3.3.3.Opportunities
3.3.3.1.Emerging markets
3.3.3.2.Emerging technologies
3.3.4.COVID-19 impact analysis
3.3.5.Player positioning
CHAPTER 4:GLOBAL ISOFLAVONES MARKET, BY SOURCE
4.1.Overview
4.1.1.Market size and forecast
4.2.Soy
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Red clover
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:GLOBAL ISOFLAVONES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Pharmaceuticals
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.2.3.Market analysis, by country
5.3.Nutraceuticals
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.4.Cosmetics
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country
5.5.Food & beverages
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast
5.5.3.Market analysis, by country
CHAPTER 6:GLOBAL ISOFLAVONES MARKET, BY FORM
6.1.Overview
6.1.1.Market size and forecast
6.2.Powder
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market analysis, by country
6.3.Liquid
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market analysis, by country
CHAPTER 7:ISOFLAVONES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by source
7.2.3.Market size and forecast, by application
7.2.4.Market size and forecast, by form
7.2.5.Market size and forecast, by country
7.2.6.U.S.
7.2.6.1.Market size and forecast, by source
7.2.6.3.Market size and forecast, by application
7.2.6.4.Market size and forecast, by form
7.2.7.Canada
7.2.7.1.Market size and forecast, by source
7.2.7.3.Market size and forecast, by application
7.2.7.4.Market size and forecast, by form
7.2.8.Mexico
7.2.8.1.Market size and forecast, by source
7.2.8.3.Market size and forecast, by application
7.2.8.4.Market size and forecast, by form
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by source
7.3.3.Market size and forecast, by application
7.3.4.Market size and forecast, by form
7.3.5.Market size and forecast, by country
7.3.6.UK
7.3.6.1.Market size and forecast, by source
7.3.6.3.Market size and forecast, by application
7.3.6.4.Market size and forecast, by form
7.3.7.Germany
7.3.7.1.Market size and forecast, by source
7.3.7.3.Market size and forecast, by application
7.3.7.4.Market size and forecast, by form
7.3.8.France
7.3.8.1.Market size and forecast, by source
7.3.8.3.Market size and forecast, by application
7.3.8.4.Market size and forecast, by form
7.3.9.Italy
7.3.9.1.Market size and forecast, by source
7.3.9.3.Market size and forecast, by application
7.3.9.4.Market size and forecast, by form
7.3.10.Spain
7.3.10.1.Market size and forecast, by source
7.3.10.3.Market size and forecast, by application
7.3.10.4.Market size and forecast, by form
7.3.11.Netherlands
7.3.11.1.Market size and forecast, by source
7.3.11.3.Market size and forecast, by application
7.3.11.4.Market size and forecast, by form
7.3.12.Rest of Europe
7.3.12.1.Market size and forecast, by source
7.3.12.3.Market size and forecast, by application
7.3.12.4.Market size and forecast, by form
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by source
7.4.3.Market size and forecast, by application
7.4.4.Market size and forecast, by form
7.4.5.Market size and forecast, by country
7.4.6.China
7.4.6.1.Market size and forecast, by source
7.4.6.3.Market size and forecast, by application
7.4.6.4.Market size and forecast, by form
7.4.7.Japan
7.4.7.1.Market size and forecast, by source
7.4.7.3.Market size and forecast, by application
7.4.7.4.Market size and forecast, by form
7.4.8.India
7.4.8.1.Market size and forecast, by source
7.4.8.3.Market size and forecast, by application
7.4.8.4.Market size and forecast, by form
7.4.9.South Korea
7.4.9.1.Market size and forecast, by source
7.4.9.3.Market size and forecast, by application
7.4.9.4.Market size and forecast, by form
7.4.10.Australia
7.4.10.1.Market size and forecast, by source
7.4.10.3.Market size and forecast, by application
7.4.10.4.Market size and forecast, by form
7.4.11.Rest of Asia-Pacific
7.4.11.1.Market size and forecast, by source
7.4.11.3.Market size and forecast, by application
7.4.11.4.Market size and forecast, by form
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by source
7.5.3.Market size and forecast, by application
7.5.4.Market size and forecast, by form
7.5.5.Market size and forecast, by country
7.5.6.Brazil
7.5.6.1.Market size and forecast, by source
7.5.6.3.Market size and forecast, by application
7.5.6.4.Market size and forecast, by form
7.5.7.South Africa
7.5.7.1.Market size and forecast, by source
7.5.7.3.Market size and forecast, by application
7.5.7.4.Market size and forecast, by form
7.5.8.Argentina
7.5.8.1.Market size and forecast, by source
7.5.8.3.Market size and forecast, by application
7.5.8.4.Market size and forecast, by form
7.5.9.Saudi Arabia
7.5.9.1.Market size and forecast, by source
7.5.9.3.Market size and forecast, by application
7.5.9.4.Market size and forecast, by form
7.5.10.Rest of LAMEA
7.5.10.1.Market size and forecast, by source
7.5.10.3.Market size and forecast, by application
7.5.10.4.Market size and forecast, by form
CHAPTER 8:COMPETITION LANDSCAPE
8.1.Top winning strategies
8.2.Product mapping
8.3.Competitive dashboard
8.4.Competitive heatmap
8.5.Key developments
8.5.1.Acquisition
8.5.2.Business expansion
8.5.3.Joint venture
CHAPTER 9:COMPANY PROFILES
9.1.Archer-Daniels-Midland Company (ADM)
9.1.1.Company overview
9.1.2.Key executives
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.R&D expenditure
9.1.7.Business performance
9.1.8.Key strategic moves and developments
9.2.BASF SE
9.2.1.Company overview
9.2.2.Key executives
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.Business performance
9.3.Biomax Life Sciences Limited
9.3.1.Company overview
9.3.2.Key executives
9.3.3.Company snapshot
9.3.4.Product portfolio
9.4.Cargill, Inc.
9.4.1.Company overview
9.4.2.Key executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.Business performance
9.4.7.Key strategic moves and developments
9.5.DSM
9.5.1.Company overview
9.5.2.Key executives
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio
9.5.6.R&D expenditure
9.5.7.Business performance
9.6.Herbo Nutra
9.6.1.Company overview
9.6.2.Key executives
9.6.3.Company snapshot
9.6.4.Product portfolio
9.7.International Flavors and Fragrances
9.7.1.Company overview
9.7.2.Key executives
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio
9.7.6.R&D expenditure
9.7.7.Business performance
9.7.8.Key strategic moves and developments
9.8.Nexira Inc
9.8.1.Company overview
9.8.2.Key executives
9.8.3.Company snapshot
9.8.4.Product portfolio
9.9.NutraScience Labs
9.9.1.Company overview
9.9.2.Key executives
9.9.3.Company snapshot
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.Shanghai Freemen
9.10.1.Company overview
9.10.2.Key executives
9.10.3.Company snapshot
9.10.4.Product portfolio
LIST OF TABLES
TABLE 01.GLOBAL ISOFLAVONES, MARKET BY SOURCE, 2020–2030 ($MILLION)
TABLE 02.SOY ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 03.RED CLOVER ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 04.OTHERS ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 05.GLOBAL ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 06.ISOFLAVONES MARKET FOR PHARMACEUTICALS, BY REGION, 2020–2030 ($MILLION)
TABLE 07.ISOFLAVONES MARKET FOR NUTRACEUTICALS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.ISOFLAVONES MARKET FOR COSMETICS, BY REGION, 2020–2030 ($MILLION)
TABLE 09.ISOFLAVONES MARKET FOR FOOD & BEVERAGES, BY REGION, 2020–2030 ($MILLION)
TABLE 10.GLOBAL ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 11.POWDER ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 12.LIQUID ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 13.GLOBAL ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 14.NORTH AMERICA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 15.NORTH AMERICA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 16.NORTH AMERICA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 18.U.S. ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 19.U.S. ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 20.U.S. ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 21.CANADA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 22.CANADA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.CANADA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 24.MEXICO ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 25.MEXICO ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 26.MEXICO ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 27.EUROPE ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 28.EUROPE ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 29.EUROPE ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 30.EUROPE ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31.UK ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 32.UK ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33.UK ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 34.GERMANY ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 35.GERMANY ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 36.GERMANY ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 37.FRANCE ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 38.FRANCE ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 39.FRANCE ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 40.ITALY ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 41.ITALY ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 42.ITALY ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 43.SPAIN ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 44.SPAIN ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 45.SPAIN ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 46.NETHERLANDS ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 47.NETHERLANDS ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 48.NETHERLANDS ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 49.REST OF EUROPE ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 50.REST OF EUROPE ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51.REST OF EUROPE ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 52.ASIA-PACIFIC ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 53.ASIA-PACIFIC ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 54.ASIA-PACIFIC ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 55.ASIA-PACIFIC ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 56.CHINA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 57.CHINA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 58.CHINA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 59.JAPAN ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 60.JAPAN ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 61.JAPAN ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 62.INDIA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 63.INDIA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 64.INDIA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 66.SOUTH KOREA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67.SOUTH KOREA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 68.AUSTRALIA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 69.AUSTRALIA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 70.AUSTRALIA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 74.LAMEA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 75.LAMEA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 76.LAMEA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 77.LAMEA ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 78.BRAZIL ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 79.BRAZIL ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 80.BRAZIL ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 82.SOUTH AFRICA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 83.SOUTH AFRICA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 84.ARGENTINA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 85.ARGENTINA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 86.ARGENTINA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 87.SAUDI ARABIA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 88.SAUDI ARABIA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 89.SAUDI ARABIA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 90.REST OF LAMEA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 91.REST OF LAMEA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 92.REST OF LAMEA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 93.ADM: KEY EXECUTIVES
TABLE 94.ADM: COMPANY SNAPSHOT
TABLE 95.ADM: OPERATING SEGMENTS
TABLE 96.ADM: PRODUCT PORTFOLIO
TABLE 97.ADM: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 98.ADM: NET SALES, 2018–2020 ($MILLION)
TABLE 99.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.BASF SE: KEY EXECUTIVES
TABLE 101.BASF SE: COMPANY SNAPSHOT
TABLE 102.BASF SE: OPERATING SEGMENTS
TABLE 103.BASF SE: PRODUCT PORTFOLIO
TABLE 104.BASF SE: NET SALES, 2018–2020 ($MILLION)
TABLE 105.BIOMAX LIFE SCIENCES LIMITED: KEY EXECUTIVES
TABLE 106.BIOMAX LIFE SCIENCES LIMITED: COMPANY SNAPSHOT
TABLE 107.BIOMAX LIFE SCIENCES LIMITED: PRODUCT PORTFOLIO
TABLE 108.CARGILL, INC.: KEY EXECUTIVES
TABLE 109.CARGILL, INC.: COMPANY SNAPSHOT
TABLE 110.CARGILL, INC.: OPERATING SEGMENTS
TABLE 111.CARGILL, INC.: PRODUCT PORTFOLIO
TABLE 112.CARGILL, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 113.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114.DSM: KEY EXECUTIVES
TABLE 115.DSM: COMPANY SNAPSHOT
TABLE 116.DSM: OPERATING SEGMENTS
TABLE 117.DSM: PRODUCT PORTFOLIO
TABLE 118.DSM: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 119.DSM: NET SALES, 2018–2020 ($MILLION)
TABLE 120.HERBO NUTRA: KEY EXECUTIVES
TABLE 121.HERBO NUTRA: COMPANY SNAPSHOT
TABLE 122.HERBO NUTRA: PRODUCT PORTFOLIO
TABLE 123.INTERNATIONAL FLAVORS AND FRAGRANCES: KEY EXECUTIVES
TABLE 124.INTERNATIONAL FLAVORS AND FRAGRANCES: COMPANY SNAPSHOT
TABLE 125.INTERNATIONAL FLAVORS AND FRAGRANCES: OPERATING SEGMENTS
TABLE 126.INTERNATIONAL FLAVORS AND FRAGRANCES: PRODUCT PORTFOLIO
TABLE 127.INTERNATIONAL FLAVORS AND FRAGRANCES: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 128.INTERNATIONAL FLAVORS AND FRAGRANCES: NET SALES, 2018–2020 ($MILLION)
TABLE 129.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130.NEXIRA INC: KEY EXECUTIVES
TABLE 131.NEXIRA INC: COMPANY SNAPSHOT
TABLE 132.NEXIRA INC: PRODUCT PORTFOLIO
TABLE 133.NUTRASCIENCE LABS: KEY EXECUTIVES
TABLE 134.NUTRASCIENCE LABS: COMPANY SNAPSHOT
TABLE 135.NUTRASCIENCE LABS: PRODUCT PORTFOLIO
TABLE 136.NUTRASCIENCE LABS: NET SALES, 2018–2020 ($MILLION)
TABLE 137.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 138.SHANGHAI FREEMEN: KEY EXECUTIVES
TABLE 139.SHANGHAI FREEMEN: COMPANY SNAPSHOT
TABLE 140.SHANGHAI FREEMEN: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.GLOBAL ISOFLAVONES MARKET
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05.HIGH BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.LOW THREAT OF SUBSTITUTES
FIGURE 08.LOW INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.GLOBAL ISOFLAVONES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES, 2020–2030
FIGURE 10.GLOBAL ISOFLAVONES MARKET SHARE, BY SOURCE, 2020–2030
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF SOY ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF RED CLOVER ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF OTHERS ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.GLOBAL ISOFLAVONES MARKET SHARE, BY APPLICATION, 2020–2030
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR PHARMACEUTICALS ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR NUTRACEUTICALS ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR COSMETICS ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR FOOD & BEVERAGES ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 19.GLOBAL ISOFLAVONES MARKET SHARE, BY FORM, 2020–2030
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF POWDER ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF LIQUID ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 22.GLOBAL ISOFLAVONES MARKET SHARE, BY REGION, 2020–2030
FIGURE 23.U.S. ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 24.CANADA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 25.MEXICO ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 26.UK ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 27.GERMANY ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 28.FRANCE ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 29.ITALY ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 30.SPAIN ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 31.NETHERLANDS ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 32.REST OF EUROPE ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 33.CHINA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 34.JAPAN ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 35.INDIA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 36.SOUTH KOREA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 37.AUSTRALIA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 38.REST OF ASIA-PACIFIC ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 39.BRAZIL ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 40.SOUTH AFRICA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 41.ARGENTINA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 42.SAUDI ARABIA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 43.REST OF LAMEA ISOFLAVONES MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 44.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 45.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 46.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 47.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 48.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 50.ADM: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 51.ADM: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.ADM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53.ADM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54.BASF SE: NET SALES, 2018–2020 ($MILLION)
FIGURE 55.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57.CARGILL, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 58.CARGILL, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 59.DSM: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 60.DSM: NET SALES, 2018–2020 ($MILLION)
FIGURE 61.DSM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 62.DSM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63.INTERNATIONAL FLAVORS AND FRAGRANCES: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 64.INTERNATIONAL FLAVORS AND FRAGRANCES: NET SALES, 2018–2020 ($MILLION)
FIGURE 65.INTERNATIONAL FLAVORS AND FRAGRANCES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 66.INTERNATIONAL FLAVORS AND FRAGRANCES: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 67.NUTRASCIENCE LABS: NET SALES, 2018–2020 ($MILLION)
According to the insights of CXOs of leading companies, a variety of health benefits have been linked to isoflavones. Isoflavones, which are found in soy foods, can aid in the maintenance of blood vessel health. Consumption of isoflavones-containing foods may boost the body's antioxidant levels and aid in cellular health.
Isoflavones lower the risk of breast cancer and also prevent cancer cell growth by reducing cell multiplication. These are also important sources of antioxidants, which lower cholesterol levels, protecting the cardiovascular system and lowering the risk of stroke and coronary heart disease.
Furthermore, isoflavones promote bone formation and increase bone mass. These are also used in cosmetics to treat skin firming and wrinkles as well as to protect the skin from sun damage and as a moisturizing agent. In cosmetics, isoflavones are used to treat sun damage, wrinkles, skin firming, and as a moisturizer. All of these factors will contribute to the global isoflavones market growth during the forecast period.
High demand for isoflavones in the pharmaceutical and healthcare industries is propelling the North America isoflavones market growth. Furthermore, low retail price and widespread availability of generic medicines containing isoflavones are fueling the market growth in North America.
A. . The global isoflavones market was valued at $975.0 million in 2020, and is projected to reach $1,707.5 million by 2030, registering a CAGR of 5.8%.
A. What is the CAGR of Isoflavones market?
A. The sample report of Isoflavones Market is available on Allied Market Research website on request. Many reports of same domain are also available on website. The customization of reports is available on demand.
A. The top companies in the isoflavones market are Cargill, Archer-Daniels-Midland (ADM) Company, Badische Anilin und Soda Fabrik (BASF), DSM, International Flavors and Fragrances, Shanghai Freemen, Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Herbo Nutra, and NutraScience Labs.
A. The isoflavones market is segmented on the basis of source, application, form, and region. On the basis of source, the market is categorized into soy, red clover, and others. As per application, the market is divided into pharmaceuticals, nutraceuticals, cosmetics, and food & beverages. According to form, the isoflavones market is fragmented into powder and liquid. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, the Netherlands, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Argentina, Saudi Arabia, and the rest of LAMEA).
A. The base year calculated in the isoflavones market is 2020.
A. The market is being driven by factors such as rapid growth in the food & beverage industries in developing countries, such as India and China, as well as increased awareness of the benefits of isoflavones products.
A. North America region holds the maximum market share of the global isoflavones market.
A. The side effects, such as thyroid disorders, food allergies, migraine headaches, and increased heart rate after excessive consumption, are limiting the growth of the global isoflavones market.
A. The pandemic of COVID-19 has raised consumer awareness of the importance of a healthy diet and supplements. Many dietary supplements and nutraceuticals products consist of isoflavones, which help to build gut health. As a result, the isoflavones market was moderately affected due to the pandemic.
Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report